Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0L35 stock hub

LON/0L35 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0L35is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0L35

In the news

Latest news · LON/0L35

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.2

P25 12.9P50 16.9P75 23.5

Trailing P/E31.4

P25 15.9P50 22.9P75 35.8

ROE4.9

P25 -54.2P50 2.1P75 13.7

ROIC0.1

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0L35 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

186

Groups with data

Currency

USD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	835
Employees Change	58%
Employees Change Percent	4.41
Enterprise value	$1.8B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US8036071004
Last refreshed	2026-05-10
Market cap	$1.5B
Price	$20.04
Price currency	USD
Rev Per Employee	1,980,950.26x
Sector	Healthcare
Sic	2836
Symbol	lon/0L35
Website	https://www.sarepta.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.19%
EV Earnings	37.25x
EV/EBITDA	12.3x
EV/FCF	21.1x
EV/Sales	1.14x
FCF yield	5.63%
Forward P/E	8.2x
P/B ratio	1.36x
P/E ratio	31.38x
P/S ratio	0.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.05%
EBITDA Margin	2.11%
FCF margin	5.26%
Gross margin	-6.49%
Gross Profit	$-107.3M
Gross Profit Growth Q	3.69%
Net Income	$49.3M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	1.12%
Profit Margin	2.98%
Profit Per Employee	$59,004
ROA	0.02
Roa5y	-6.49
ROCE	0.04
ROE	4.91
Roe5y	-55.33
ROIC	0.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-45.86%
Cagr3y	-46.68%
Cagr5y	-22.99%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-2.2x
Revenue Growth Q	-1.89x
Revenue Growth Years	10x
Revenue Growth3 Y	30.82x
Revenue Growth5 Y	30.67x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.66
Assets	$2.4B
Cash	$494.7M
Current Assets	$1.7B
Current Liabilities	$366.1M
Debt	$792.9M
Debt EBITDA	$5.15
Debt Equity	$0.7
Debt FCF	$9.11
Equity	$1.1B
Interest Coverage	0.02
Liabilities	$1.3B
Long Term Assets	$713.1M
Long Term Liabilities	$901.5M
Net Cash	$-298.3M
Net Cash By Market Cap	$-19.29
Net Debt EBITDA	$8.53
Net Debt Equity	$0.26
Net Debt FCF	$3.43
Tangible Book Value	$1.1B
Tangible Book Value Per Share	$10.57
WACC	5.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.63
Inventory Turnover	2.39
Net Working Capital	$884.5M
Quick ratio	2.41
Working Capital	$1.4B
Working Capital Turnover	$0.91

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.78%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-45.84%
200-day SMA	19.74
3Y total return	-84.85%
50-day SMA	19.66
50-day SMA vs 200-day SMA	50under200
5Y total return	-72.9%
All Time High	175.1
All Time High Change	-88.55%
All Time High Date	2024-06-21
All Time Low	10.49
All Time Low Change	91.14%
All Time Low Date	2025-07-24
ATR	1.38
Beta	0.26
Ch YTD	-7.73
High	21
High52	44.11
High52 Date	2025-05-21
High52ch	-54.57%
Low	19.94
Low52	10.49
Low52 Date	2025-07-24
Low52ch	91.14%
Ma50ch	1.94%
Price vs 200-day SMA	1.52%
RSI	49.43
RSI Monthly	31.6
RSI Weekly	47.03
Sharpe ratio	-0.45x
Sortino ratio	-0.52
Total Return	-10.78%
Tr YTD	-7.73
Tr1m	-12.64%
Tr1w	-6.44%
Tr3m	9.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$792,898
Operating margin	0.05

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	93,469,779%
Net Borrowing	-116,905,994.3
Shares Insiders	4.12%
Shares Institutions	82.27%
Shares Qo Q	16.34%
Shares Yo Y	10.78%
Short Ratio	8.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$2.7M
Average Volume	5,801.95x
Bv Per Share	10.8
CAPEX	$-45.7M
Ch1m	-12.64
Ch1w	-6.44
Ch1y	-45.84
Ch3m	9.16
Ch3y	-84.85
Ch5y	-72.9
Ch6m	15.91
Change	-3.04%
Change From Open	-3.19
Close	20.67
Days Gap	0.15
Depreciation Amortization	33,108,621.4
Dollar Volume	44,871.1
Earnings Date	2026-05-06
EBIT	$792,898
EBITDA	$35M
EPS	$0.48
F Score	6
FCF	$87M
FCF EV Yield	4.74x
Financing CF	-136,749,593
Fiscal Year End	December
Founded	1,980
Graham Number	14.57008
Graham Upside	-27.3
Income Tax	$-30.7M
Investing CF	171,475,057
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Ma150	20.4
Ma150ch	-1.76%
Ma20	21.15
Ma20ch	-5.25%
Net CF	167,462,097
Open	20.7
P FCF Ratio	17.77
P OCF Ratio	11.65
Position In Range	9.5
Ppne	337,636,494.2
Price Date	2026-05-08
Price EBITDA	$44.21
Ptbv Ratio	1.39
Relative Volume	0.5x
Revenue	1,654,093,464x
SBC By Revenue	5.1x
Share Based Comp	84,338,786
Tax By Revenue	-1.86x
Tr6m	15.91%
Volume	2,239
Z Score	0.28

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0L35 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0L35 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0L35?

Insider, institutional, and short-interest positioning.

Institutional ownership

+82.3%

Share of float held by funds and institutions

Insider ownership

+4.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0L35 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.4

Neutral momentum band

Price vs 200-day MA

+1.5%

50/200-day relationship not available

Beta (5Y)

0.26

Less volatile than the market

Sharpe ratio

-0.45

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0L35

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0L35 stock rating?

lon/0L35 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0L35 analysis?

The full report lives at /stocks/lon/0L35/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0L35?

The latest report frames lon/0L35 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0L35 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.